Dernek Hakkında Tıbbi Onkoloji Derneği Haberler

Annals of Oncology - Kasım 2010

Volume 21 Issue 11 November 2010

Docetaxel-based combination therapy for castration-resistant prostate cancer
M. D. Galsky and N. J. Vogelzang 
Ann Oncol (2010) 21(11): 2135-2144 first published online March 29, 2010 doi:10.1093/annonc/mdq050  Abstract
Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?
C. Zielinski,  J. Gralow,  and M. Martin 
Ann Oncol (2010) 21(11): 2145-2152 first published online March 23, 2010 doi:10.1093/annonc/mdq069  Abstract 
Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancer
R. B. Costa,  G. Kurra,  L. Greenberg,  and C. E. Geyer 
 Ann Oncol (2010) 21(11): 2153-2160 first published online March 29, 2010 doi:10.1093/annonc/mdq096  Abstract
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
Eidtmann, R. de Boer, N. Bundred,  A. Llombart-Cussac,  N. Davidson,  P. Neven,  G. von Minckwitz,  J. Miller,  N. Schenk,  and R. Coleman  Ann Oncol (2010)21(11):2188-2194first published online May 5, 2010 doi:10.1093/annonc/mdq217  Abstract
J. Sehouli,  K. Pietzner,  P. Harter,  K. Münstedt,  S. Mahner,  A. Hasenburg,  O. Camara,  P. Wimberger,  D. Boehmer,  K. J. Buehling,  R. Richter,  K. El Khalfaoui,  and G. Oskay-Ozcelik 
Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study Ann Oncol (2010) 21(11): 2201-2205 first published online May 3, 2010 doi:10.1093/annonc/mdq229  Abstract
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006
L. N. van Steenbergen,  M. A. G. Elferink,  P. Krijnen,  V. E. P. P. Lemmens,  S. Siesling,  H. J. T. Rutten,  D. J. Richel,  H. E. Karim-Kos,  J. W. W. Coebergh,  and on behalf of the Working Group Output of The Netherlands Cancer Registry 
 Ann Oncol (2010) 21(11): 2206-2212 first published online May 3, 2010 doi:10.1093/annonc/mdq227
Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study
S. Rao,  N. Starling,  D. Cunningham,  K. Sumpter,  D. Gilligan,  T. Ruhstaller,  M. Valladares-Ayerbes,  H. Wilke,  C. Archer,  R. Kurek,  C. Beadman,  and J. Oates 
 Ann Oncol (2010) 21(11): 2213-2219 first published online May 23, 2010 doi:10.1093/annonc/mdq247  Abstract 
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
G. P. Stathopoulos,  D. Antoniou,  J. Dimitroulis,  P. Michalopoulou,  A. Bastas,  K. Marosis,  J. Stathopoulos,  A. Provata,  P. Yiamboudakis,  D. Veldekis,  N. Lolis,  N. Georgatou,  M. Toubis,  Ch. Pappas,  and G. Tsoukalas 
 Ann Oncol (2010) 21(11): 2227-2232 first published online May 3, 2010 doi:10.1093/annonc/mdq234  Abstract 
Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
V. A. Passero,  B. F. Branstetter,  Y. Shuai,  D. E. Heron,  M. K. Gibson,  S. Y. Lai,  S. W. Kim,  J. R. Grandis,  R. L. Ferris,  J. T. Johnson,  and A. Argiris 
 Ann Oncol (2010) 21(11): 2278-2283 first published online April 29, 2010 doi:10.1093/annonc/mdq226  Abstract 
Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial
A. Sharma,  B. K. Mohanti,  A. Thakar,  S. Bahadur,  and S. Bhasker  Ann Oncol (2010)21(11):2272-2277first published online April 28, 2010 doi:10.1093/annonc/mdq219  Abstract